In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 3.78 below Omniab Inc average.

Within Medical Laboratories industry 11 other companies have achieved higher Quick Ratio than Omniab Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 533 to 961.

Explain Quick Ratio?
How much Cash & cash equivalents OABI�s has?
What are OABI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OABI Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	76.14 %	13.92 %	2.73 %	-4.45 %	1.63 %
Y / Y Cash & cash equivalent Change	24.94 %	12.56 %	-9.1 %	0.2 %	-27.28 %
Quick Ratio MRQ	3.78	7.34	5.86	7.65	5.33
OABI's Total Ranking	# 961	# 533	# 0	# 204	#
Seq. Current Liabilities Change	105.8 %	-27.45 %	18.42 %	-0.38 %	33.11 %
Seq. Cash & cash equivalent Change	5.96 %	-9.17 %	-9.2 %	42.98 %	-4.54 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 12
Healthcare Sector	# 354
Overall Market	# 961

Quick Ratio Statistics
High	Average	Low
1902.37	95.72	0
(Jun 30 2021)		(Sep 30 2022)

Financial Statements
Omniab Inc 's Current Liabilities	$ 14 Millions	Visit OABI's Balance sheet
Omniab Inc 's Cash & cash equivalent	$ 52 Millions	Visit OABI's Balance sheet
Source of OABI's Sales		Visit OABI's Sales by Geography

Cumulative Omniab Inc 's Quick Ratio

OABI's Quick Ratio for the trailling 12 Months

OABI Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	21.59 %	2.69 %	-7.81 %	-19.19 %	-29.6 %
Y / Y Cash & cash equivalent TTM Growth	5.18 %	-7.02 %	-18.9 %	-25.11 %	-34.15 %
Quick Ratio TTM	5.73	6.48	6.48	6.71	6.63
Total Ranking TTM	# 3830	# 3737	# 0	# 1676	#
Seq. Current Liabilities TTM Growth	18.88 %	2.66 %	0.81 %	-1.18 %	0.41 %
Seq. Cash & cash equivalent TTM Growth	5.08 %	2.76 %	-2.65 %	0.06 %	-7.11 %

Quick ratio ranking by company, industry and sector >> Back to OABI Financial Strength Comparisons >> Go to Compare OABI Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q2 2026 to $13.76 millions, cumulative Quick Ratio decreased to 5.73 above the OABI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 33 other companies have achieved higher Quick Ratio than Omniab Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3737 to 3830.

Explain Quick Ratio?
How much Cash & cash equivalents OABI�s has?
What are OABI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 34
Healthcare Sector	# 884
Within the Market	# 3830

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.89	1.08	0.02
(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Laboratories Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Grail Inc	10.29	$ 859.755 Millions	$ 83.542 Millions
Absci Corp	10.12	$ 201.142 Millions	$ 19.878 Millions
Billiontoone Inc	9.85	$ 548.628 Millions	$ 55.725 Millions
Celcuity Inc	8.68	$ 754.000 Millions	$ 86.873 Millions
Veracyte Inc	7.76	$ 487.046 Millions	$ 62.736 Millions
Personalis Inc	6.00	$ 278.411 Millions	$ 46.385 Millions
Castle Biosciences Inc	4.72	$ 266.805 Millions	$ 56.509 Millions
Bionexus Gene Lab Corp	4.33	$ 3.522 Millions	$ 0.813 Millions
Caredx Inc	3.99	$ 373.636 Millions	$ 93.698 Millions
Omniab Inc	3.78	$ 51.995 Millions	$ 13.758 Millions
Fulgent Genetics Inc	3.58	$ 257.032 Millions	$ 71.756 Millions
Guardant Health Inc	3.11	$ 1,053.469 Millions	$ 338.962 Millions
Butterfly Network Inc	2.13	$ 124.659 Millions	$ 58.603 Millions
Natera Inc	1.97	$ 1,091.502 Millions	$ 553.200 Millions
Biodesix Inc	1.96	$ 29.996 Millions	$ 15.291 Millions
Sera Prognostics Inc	1.91	$ 46.445 Millions	$ 24.356 Millions
Exagen Inc	1.83	$ 24.588 Millions	$ 13.457 Millions
Radnet Inc	1.11	$ 773.510 Millions	$ 697.822 Millions
Bioaffinity Technologies Inc	0.91	$ 2.430 Millions	$ 2.681 Millions

Date modified: 2026-09-05T15:23:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.